Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 202

1.
2.

Intracellular signalling: phosphatidylinositol lipid metabolism in cancer cells.

Singhal RL, Prajda N, Weber G.

Indian J Biochem Biophys. 1997 Feb-Apr;34(1-2):25-8.

PMID:
9343925
3.

Current issues in the regulation of signal transduction.

Weber G, Prajda N, Yang H, Yeh YA, Shen F, Singhal RL, Herenyiova M, Look KY.

Adv Enzyme Regul. 1996;36:33-55.

PMID:
8869739
4.

Quercetin down-regulates signal transduction in human breast carcinoma cells.

Singhal RL, Yeh YA, Praja N, Olah E, Sledge GW Jr, Weber G.

Biochem Biophys Res Commun. 1995 Mar 8;208(1):425-31.

PMID:
7887960
6.

Regulation of signal transduction.

Weber G, Singhal RL, Prajda N, Yeh YA, Look KY, Sledge GW Jr.

Adv Enzyme Regul. 1995;35:1-21.

PMID:
7572337
7.
8.

Coordinated increase in activities of the signal transduction enzymes PI kinase and PIP kinase in human cancer cells.

Singhal RL, Yeh YA, Look KY, Sledge GW Jr, Weber G.

Life Sci. 1994;55(19):1487-92.

PMID:
7968216
9.

Antimetabolites reduce the activities of enzymes with short half-lives in addition to inhibiting their specific targets.

Weber G, Prajda N, Singhal RL.

Adv Exp Med Biol. 1994;370:145-50. Review. No abstract available.

PMID:
7660878
10.

Sequential impact of tiazofurin and ribavirin on the enzymic program of the bone marrow.

Prajda N, Hata Y, Abonyi M, Singhal RL, Weber G.

Cancer Res. 1993 Dec 15;53(24):5982-6.

PMID:
7903199
11.

Nutritional and hormonal regulation of liver deoxycytidine kinase activity.

Singhal RL, Abonyi M, Weber G.

Biochem Biophys Res Commun. 1993 Jul 15;194(1):45-9.

PMID:
7687437
12.

Regulation of deoxycytidine kinase activity and inhibition by DFDC.

Weber G, Singhal RL, Abonyi M, Prajda N, Hata Y, Szekeres T, Yeh A, Look KY.

Adv Enzyme Regul. 1993;33:39-59.

PMID:
8356916
13.

Deoxycytidine kinase and thymidine kinase activities in rat brain.

Singhal RL, Weber G.

Oncol Res. 1993;5(4-5):191-5.

PMID:
8305745
14.

Increased deoxycytidine kinase activity in cancer cells and inhibition by difluorodeoxycytidine.

Singhal RL, Yeh YA, Szekeres T, Weber G.

Oncol Res. 1992;4(11-12):517-22.

PMID:
1299379
15.
16.

Hormone-independent polyamine metabolism of squamous cell carcinoma of the prostate.

Shukla GS, Singhal RL.

Cell Biochem Funct. 1985 Jul;3(3):185-92.

PMID:
3836020
17.

Titrimetric determination of vanadium(IV) with DCTA.

Parkash R, Singh K, Pal Kaur J, Singhal RL.

Talanta. 1984 Sep;31(9):717-9.

PMID:
18963685
18.
19.

The present status of biological effects of toxic metals in the environment: lead, cadmium, and manganese.

Shukla GS, Singhal RL.

Can J Physiol Pharmacol. 1984 Aug;62(8):1015-31. Review.

PMID:
6149004
20.

The effects of low-level lead exposure in developing rats: changes in circadian locomotor activity and hippocampal noradrenaline turnover.

Collins MF, Hrdina PD, Whittle E, Singhal RL.

Can J Physiol Pharmacol. 1984 Apr;62(4):430-5.

PMID:
6733588
21.

Psychiatric progress. The learned helplessness model of depression.

Telner JI, Singhal RL.

J Psychiatr Res. 1984;18(3):207-15.

PMID:
6492008
23.

Androgen dependence of glutathione metabolism in ventral prostate.

Vijayvargiya R, Singhal RL.

Biochem Pharmacol. 1983 Sep 1;32(17):2607-10. No abstract available.

PMID:
6225436
24.

A perspective: psychopharmacological aspects of aggression in animals and man.

Singhal RL, Telner JI.

Psychiatr J Univ Ott. 1983 Sep;8(3):145-53. Review. No abstract available.

PMID:
6139834
25.

Effects of subacute low level lead exposure on glucose homeostasis.

Whittle E, Singhal RL, Collins M, Hrdina PD.

Res Commun Chem Pathol Pharmacol. 1983 Apr;40(1):141-54.

PMID:
6306742
26.
27.

SL76002 - effect on gamma-aminobutyric acid and dopamine in animals treated chronically with haloperidol.

Rastogi SK, Rastogi RB, Singhal RL, Lapierre YD.

Neuropsychobiology. 1983;9(4):211-4.

PMID:
6646392
28.

Fluvoxamine influences serotonergic system in the brain: neurochemical evidence.

Lapierre YD, Rastogi RB, Singhal RL.

Neuropsychobiology. 1983;10(4):213-6.

PMID:
6427651
30.

Behavioural and biochemical alterations following haloperidol treatment and withdrawal: the animal model of tardive dyskinesia reexamined.

Rastogi SK, Rastogi RB, Singhal RL, Lapierre YD.

Prog Neuropsychopharmacol Biol Psychiatry. 1983;7(2-3):153-64.

PMID:
6137027
31.

Lead in blood and brain regions of rats chronically exposed to low doses of the metal.

Collins MF, Hrdina PD, Whittle E, Singhal RL.

Toxicol Appl Pharmacol. 1982 Sep 15;65(2):314-22. No abstract available.

PMID:
7179287
32.

3',5'-cyclic-nucleotide-dependent protein kinase of squamous cell carcinoma of the prostate.

Vijayvargiya R, Singhal RL.

Biosci Rep. 1982 Sep;2(9):675-85.

PMID:
6291670
33.

Effects of cholinergic and GABAergic drugs on apomorphine-induced gnawing behavior in rats.

Rastogi SK, Rastogi RB, Singhal RL, Lapierre YD.

Biol Psychiatry. 1982 Aug;17(8):937-46.

PMID:
6288127
34.

MIF-1: effects on norepinephrine, dopamine and serotonin metabolism in certain discrete brain regions.

Singhal RL, Rastogi RB.

Pharmacol Biochem Behav. 1982 Feb;16(2):229-33.

PMID:
6122214
35.

Stress controllability and plasma prolactin levels in the rat.

Telner JI, Merali Z, Singhal RL.

Psychoneuroendocrinology. 1982;7(4):361-4. No abstract available.

PMID:
7167631
36.

Effect of baclofen and haloperidol on gamma-aminobutyric acid and dopamine systems in an animal model of tardive dyskinesia.

Rastogi SK, Rastogi RB, Lapierre YD, Singhal RL.

Gen Pharmacol. 1982;13(6):499-504. No abstract available.

PMID:
7152230
37.

Time-dependent changes in plasma prolactin level and stress controllability in rats.

Telner JI, Merali Z, Singhal RL.

Prog Neuropsychopharmacol Biol Psychiatry. 1982;6(4-6):459-62.

PMID:
6891813
38.

Bromocriptine-induced changes in dopamine and gamma aminobutyric acid in haloperidol withdrawn rats.

Rastogi RB, Rastogi SK, Lapierre YD, Singhal RL.

Prog Neuropsychopharmacol Biol Psychiatry. 1982;6(4-6):443-7.

PMID:
6891811
39.

Effect of lithium treatment and withdrawal on uptake of noradrenaline into rat brain synaptosomes: a kinetic study.

Ahluwalia P, Singhal RL.

Prog Neuropsychopharmacol Biol Psychiatry. 1982;6(4-6):339-42. No abstract available.

PMID:
6819595
40.
41.

Thyrotropin releasing hormone potentiates the effects of imipramine on brain serotonergic system.

Rastogi RB, Singhal RL, Lapierre YD.

Brain Res Bull. 1981 Oct;7(4):449-51.

PMID:
6170395
42.

Effects of short- and long-term neuroleptic treatment on brain serotonin synthesis and turnover: focus on the serotonin hypothesis of schizophrenia.

Rastogi RB, Singhal RL, Lapierre YD.

Life Sci. 1981 Aug 17;29(7):735-41. No abstract available.

PMID:
6168884
43.

MK-771 enhances the turnover of norepinephrine in brain.

Rastogi RB, Singhal RL.

Res Commun Chem Pathol Pharmacol. 1981 Jul;33(1):187-90.

PMID:
6115460
44.

Effects of nortriptyline treatment on learned helplessness in the rat.

Telner JI, Singhal RL.

Pharmacol Biochem Behav. 1981 Jun;14(6):823-6.

PMID:
7196048
45.

Monoamine uptake into synaptosomes from various regions of rat brain following lithium administration and withdrawal.

Ahluwalia P, Singhal RL.

Neuropharmacology. 1981 May;20(5):483-7. No abstract available.

PMID:
6787450
46.
47.
48.

Reversal of learned helplessness by nortriptyline.

Telner JI, Singhal RL, Lapierre YD.

Prog Neuropsychopharmacol. 1981;5(5-6):587-90. No abstract available.

PMID:
7200250
49.

Brain gabaergic and dopaminergic systems following lithium treatment and withdrawal.

Ahluwalia P, Grewaal DS, Singhal RL.

Prog Neuropsychopharmacol. 1981;5(5-6):527-30. No abstract available.

PMID:
7200249
50.

Neurochemical changes produced by acute treatment with clobazam, a new 1,5-benzodiazepine.

Lapierre YD, Rastogi RB, Singhal RL.

Gen Pharmacol. 1981;12(4):261-6. No abstract available.

PMID:
6114016

Supplemental Content

Loading ...
Support Center